| Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy AR Kirtane, O Abouzid, D Minahan, T Bensel, AL Hill, C Selinger, ... Nature communications 9 (1), 1-12, 2018 | 157 | 2018 |
| Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine JR Conway, E Kofman, SS Mo, H Elmarakeby, E Van Allen Genome medicine 10, 1-18, 2018 | 154 | 2018 |
| Tombusvirus p19 Captures RNase III-Cleaved Double-Stranded RNAs Formed by Overlapping Sense and Antisense Transcripts in Escherichia coli L Huang, P Deighan, J Jin, Y Li, HC Cheung, E Lee, SS Mo, H Hoover, ... MBio 11 (3), 10.1128/mbio. 00485-20, 2020 | 8 | 2020 |
| Primary CNS lymphoma: update on molecular pathogenesis and therapy SS Mo, J Cleveland, JL Rubenstein Leukemia & Lymphoma, 2022 | 5 | 2022 |
| Cost-effectiveness analysis of multimodal prognostication in cardiac arrest with EEG monitoring E Amorim, SS Mo, S Palacios, MM Ghassemi, WH Weng, SS Cash, ... Neurology 95 (5), e563-e575, 2020 | 4 | 2020 |
| Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine. Genome Med. 2018; 10: 93 JR Conway, E Kofman, SS Mo, H Elmarakeby, E Van Allen | 2 | |
| Tafasitamab at the blood–brain barrier AM Rauschecker, SS Mo, M Randall, J Shen‐Sampas, JL Rubenstein British Journal of Haematology 201 (1), 154-157, 2023 | 1 | 2023 |
| Next-Generation Sequencing of Newly-Diagnosed Primary CNS Lymphoma Reveals Alterations in BTG1, ETV6, and 6p Are Associated with Chemoresistance and Inferior Progression-Free … SS Mo, H Geng, M Cerejo, KW Wen, DA Solomon, JL Rubenstein Blood 140 (Supplement 1), 3516-3517, 2022 | | 2022 |
| Dissecting genomic determinants of response to platinum-based chemotherapy in advanced NSCLC and colorectal cancer SS Mo, D Liu, SW Gray, S Joffe, N Wagle, J Garber, LA Garraway, L Sholl, ... Cancer Research 78 (13_Supplement), 3254-3254, 2018 | | 2018 |
